Sharon Longhurst
Director/Board Member at IDOGEN AB (PUBL)
Sharon Longhurst active positions
Companies | Position | Start | End |
---|---|---|---|
IDOGEN AB (PUBL) | Director/Board Member | 2020-05-11 | - |
Independent Dir/Board Member | 2020-05-11 | - | |
ELICERA THERAPEUTICS AB | Director/Board Member | 2023-12-31 | - |
Independent Dir/Board Member | 2023-12-31 | - |
Career history of Sharon Longhurst
Former positions of Sharon Longhurst
Companies | Position | Start | End |
---|---|---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Corporate Officer/Principal | 2021-09-30 | 2023-07-31 |
MENDUS AB | Corporate Officer/Principal | - | - |
Training of Sharon Longhurst
University of Warwick | Doctorate Degree |
University of Surrey | Undergraduate Degree |
Statistics
International
Sweden | 4 |
United Kingdom | 3 |
Netherlands | 2 |
Operational
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
IDOGEN AB (PUBL) | Health Technology |
MENDUS AB | Health Technology |
ELICERA THERAPEUTICS AB | Health Technology |
Private companies | 1 |
---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
- Stock Market
- Insiders
- Sharon Longhurst
- Experience